Ian Fotheringham received a B.Sc. and Ph.D. in Molecular Biology from the University of Glasgow, UK in 1986. With the NutraSweet division of Monsanto in Chicago, he constructed microbes to produce the Aspartame® sweetener. From 1993 he continued developing large scale bioprocesses with NSC Technologies and Great Lakes Fine Chemicals. In 2003 he co-founded Ingenza, now a leading UK Industrial Biotechnology and Synthetic Biology company. Ingenza has a unique range of proprietary enabling technologies in the areas of industrial biotechnology, enzyme and strain improvement, synthetic biology, fermentation and GLP/GMP bioprocess development. He has published 35 papers and articles and holds 11 current patents.
A Novel Point-of-Care Diagnostic Assay to Determine the Correct Placement of Nasogastric Feeding Tubes
Thursday, 18 September 2014 at 16:45
Add to Calendar ▼2014-09-18 16:45:002014-09-18 17:45:00Europe/LondonA Novel Point-of-Care Diagnostic Assay to Determine the Correct Placement of Nasogastric Feeding TubesPoint-of-Care Diagnostics World Congress in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
Nasogastric feeding tube misplacements can and do have disastrous consequences, including patient death. Existing methods to verify tube placements, including standard pH testing and the gold-standard chest X-rays, have major drawbacks in cost, usability or safety. We have a new enzymatic bedside point-of-care test to verify correct tube placement. The test detects human gastric lipase (HGL) which is stable in gastric juice, resistant towards antacid medications, as well as unlikely to migrate. Our pilot study showed this test to be reliable and accurate, while low cost, simple and requiring no extra user training. The new test significantly outperformed the current pH test and we believe has great potential to translate into clinical practice. There is also potential for deployment of this new assay in under-resourced regions of the world, providing greater reliability for NG tube placement where more sophisticated placement confirmation methods are unavailable.
Add to Calendar ▼2014-09-18 00:00:002014-09-19 00:00:00Europe/LondonPoint-of-Care Diagnostics World CongressPoint-of-Care Diagnostics World Congress in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2014-09-18 16:45:002014-09-18 17:45:00Europe/LondonA Novel Point-of-Care Diagnostic Assay to Determine the Correct Placement of Nasogastric Feeding TubesPoint-of-Care Diagnostics World Congress in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
